Alpha-1 Antitrypsin Gene Variants and COPD
Author Information
Author(s): Denden Sabri, Khelil Amel Haj, Knani Jalel, Lakhdar Ramzi, Perrin Pascale, Lefranc Gérard, Chibani Jemni Ben
Primary Institution: Biochemistry and Molecular Biology Laboratory, Faculty of Pharmacy, Monastir, Tunisia
Hypothesis
Common AAT polymorphisms influence the risk of developing COPD.
Conclusion
The study found no significant differences in the frequency of common SERPINA1 variants between COPD patients and healthy controls.
Supporting Evidence
- No significant differences were observed in allele frequencies between COPD patients and controls.
- Haplotype analysis showed no significant differences between the two groups.
- Annual FEV1 decline revealed no difference among carriers of the tested polymorphisms.
Takeaway
This study looked at whether certain gene variations affect the risk of getting COPD, but it found that they don't seem to make a difference.
Methodology
A case-control study comparing allele frequencies and haplotypes between 100 COPD patients and 200 healthy controls.
Limitations
The study excluded AATD individuals and did not find significant relationships between the tested polymorphisms and COPD manifestations.
Participant Demographics
100 COPD patients and 200 healthy controls, with specific inclusion and exclusion criteria.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website